Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Levine

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Journal of Alzheimer'S Disease : JAD|September 18, 2010
Changes in cognition and amyloid-β processing with long term cholesterol reduction using atorvastatin in aged dogsM Paul Murphy, Jacqueline Morales, Tina L Beckett, et al.
Cornea|November 28, 2022
Combined Therapeutic Penetrating Keratoplasty and Pars Plana Vitrectomy for the Treatment of Infectious Keratitis Endophthalmitis: Mexican Endophthalmitis Study Group Protocol 4Raul Velez-Montoya, Mariana A Rivera-Cortes, Gerardo Ledesma-Gil, et al.
Nature|October 11, 2023
High-fidelity parallel entangling gates on a neutral-atom quantum computerSimon J Evered, Dolev Bluvstein, Marcin Kalinowski, et al.
Bioorganic & Medicinal Chemistry Letters|January 6, 2009
The synthesis and structure-activity relationship of substituted N-phenyl anthranilic acid analogs as amyloid aggregation inhibitorsLloyd J Simons, Bradley W Caprathe, Michael Callahan, et al.
Cornea|June 2, 2023
Automatic Classification of Slit-Lamp Photographs by Imaging IlluminationMing-Chen Lu, Callie Deng, Miles F Greenwald, et al.
Plos One|November 13, 2014
Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicityNicholas J Izzo, Jinbin Xu, Chenbo Zeng, et al.
Translational Neurodegeneration|May 12, 2023
A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheterKelsie M LaBarbera, Yvette I Sheline, Nicholas J Izzo, et al.
Plos One|November 13, 2014
Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficitsNicholas J Izzo, Agnes Staniszewski, Lillian To, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 9, 2021
Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modificationNicholas J Izzo, Carla M Yuede, Kelsie M LaBarbera, et al.
Nature|February 26, 2025
Hardware-efficient quantum error correction via concatenated bosonic qubitsHarald Putterman, Kyungjoo Noh, Connor T Hann, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Journal of Alzheimer'S Disease : JAD|September 18, 2010
Changes in cognition and amyloid-β processing with long term cholesterol reduction using atorvastatin in aged dogsM Paul Murphy, Jacqueline Morales, Tina L Beckett, et al.
Cornea|November 28, 2022
Combined Therapeutic Penetrating Keratoplasty and Pars Plana Vitrectomy for the Treatment of Infectious Keratitis Endophthalmitis: Mexican Endophthalmitis Study Group Protocol 4Raul Velez-Montoya, Mariana A Rivera-Cortes, Gerardo Ledesma-Gil, et al.
Nature|October 11, 2023
High-fidelity parallel entangling gates on a neutral-atom quantum computerSimon J Evered, Dolev Bluvstein, Marcin Kalinowski, et al.
Bioorganic & Medicinal Chemistry Letters|January 6, 2009
The synthesis and structure-activity relationship of substituted N-phenyl anthranilic acid analogs as amyloid aggregation inhibitorsLloyd J Simons, Bradley W Caprathe, Michael Callahan, et al.
Cornea|June 2, 2023
Automatic Classification of Slit-Lamp Photographs by Imaging IlluminationMing-Chen Lu, Callie Deng, Miles F Greenwald, et al.
Plos One|November 13, 2014
Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicityNicholas J Izzo, Jinbin Xu, Chenbo Zeng, et al.
Translational Neurodegeneration|May 12, 2023
A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheterKelsie M LaBarbera, Yvette I Sheline, Nicholas J Izzo, et al.
Plos One|November 13, 2014
Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficitsNicholas J Izzo, Agnes Staniszewski, Lillian To, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 9, 2021
Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modificationNicholas J Izzo, Carla M Yuede, Kelsie M LaBarbera, et al.
Nature|February 26, 2025
Hardware-efficient quantum error correction via concatenated bosonic qubitsHarald Putterman, Kyungjoo Noh, Connor T Hann, et al.
Pageof 10